Wednesday, July 16, 2025
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Fiinews
No Result
View All Result
Home Health

Investment: Excelra-Anlitiks combine deep scientific domain expertise

Fiinews by Fiinews
April 21, 2022
in Health, Investment
Reading Time: 2 mins read
A A
0
anlitiks
0
SHARES
10
VIEWS
LinkedinShare on Twitter

0:00

Brar says RapidAnalyzer™ helps execute large volumes of analytical workflows

Excelra, with offices in Hyderabad, Boston and Utrecht (the Netherlands), has made a strategic majority investment in Boston-headquartered Anlitiks, as its commitment to drug discovery and commercialization by combining deep scientific domain expertize with cutting-edge technology and analytics solutions.

The investment reinforces Excelra’s push into the Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) analytics area.

Anlitiks is a HEOR and RWE company, founded by Kannan Rajagopalan, a technology entrepreneur and a mission to help Life Sciences organizations translate real-world data rapidly into value evidence, using a unique data + platform + service approach.

The engine driving the business is Anlitiks’ RapidAnalyzer™, a flexible, data-agnostic platform that captures the entire lifecycle of HEOR/RWE from hypothesis, data integration, analysis, visualization to a research report.

RapidAnalyzer™ changes the competitive landscape by drastically reducing the time taken to gain valuable insights on large-scale data from months to just a matter of weeks.

Anandbir Brar, Chief Executive Officer at Excelra, underlined on 20 Apr 2022, “Anlitiks has a unique platform plus consulting business model, combining highly skilled and experienced HEOR experts, and an integrated platform – RapidAnalyzer™ that helps execute large volumes of analytical workflows.

“Our combined strength empowers Life Science organizations with accelerated yet informed decision-making.”

Data and Digital transformation have become a strategic imperative for the Life Sciences industry to break down silos between multi-omics, clinical trials, and real-world data. The partnership with Anlitiks augments Excelra’s vision to use domain-led data science to empower innovation from discovery to market.

Rajagopalan elaborated, “Our vision is to be a technology-enabled disruptive force in generating rapid actionable insights for the Life Science industry using real-world data. Excelra’s focus areas dovetail perfectly with our growth strategy, making it the beginning of an exciting journey.” fiinews.com

Tags: AnlitiksExcelra
ShareTweetShare

Related Posts

Jupiter Wagons
Investment

Invest: Jupiter commits Rs.3,000cr to rail projects

by Fiinews
July 15, 2025
0
15

Railway pioneering green corridor initiatives, says Gupta Private sector participation is accelerating technological advancements, with Jupiter Wagons Limited committing over...

IVCA
Investment

Invest: India requires $150-$200bn for renewables

by Fiinews
July 10, 2025
0
25

Mumbai to host Renewable Energy Summit 2025 India will require another US$150-US$200 billion investments for renewables over the next five...

Veeda Lifesciences Logo

Invest: Veeda to leverage Mango AI capabilities

July 9, 2025
13
IPA

Invest: Serendipity Space raises pre-seed round

July 5, 2025
17
Indian Steel Association

Invest: India needs $200bn for expansion of mills

July 4, 2025
19
PIB

Invest: PSBs told to strengthen credit to MSMEs

June 29, 2025
17
SBI YONO

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0
  • Technologies: Royal Diamond sponsors aerspace Industries’ drones in UAE

    0 shares
    Share 0 Tweet 0
  • Investments: Foreign investors see India as long-term destination for fund placings

    0 shares
    Share 0 Tweet 0
  • Markets: Blue Dart maintains positive outlook on India

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Market: Phantom’s Rs.59.99cr for global expansion
  • Market: Dreame launches offline strategy in India
  • Export: Govt urged to have sector-focused strategy
  • Tech: Digitate-TCL implements AI-solutions
  • Market: Watershed joins India’s dynamic economy

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports

© 2024 FIINEWS - Design and developed by 7clicksmedia.